Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...

Pretreatment 18F-PSMA-1007 PSMA PET/CT more accurately identifies prostate tumors compared with mpMRI. Fluorine-18 prostate-specific membrane antigen-1007 positron emission tomography/computed ...

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT improves locoregional staging compared with MRI in patients undergoing surgery for intermediate and high-risk prostate cancer. PSMA ...

Vinblastine Versus Vinblastine Plus Oral Estramustine Phosphate for Patients With Hormone-Refractory Prostate Cancer: A Hoosier Oncology Group and Fox Chase Network Phase III Trial PURPOSE: ...

Magnetic resonance spectroscopy imaging (MRSI) allows evaluation of the metabolic activity within the prostate gland by assessing the quantities of different metabolites. Within the prostate, the most ...

Real-time elastography (RTE) significantly improves detection of prostate cancer (PCa) and extracapsular extension compared with grey-scale ultrasonography (GSU), according to researchers. In a study ...

Association between artificial intelligence–derived tumor volume and oncologic outcomes in localized prostate cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary Cancers ...